Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial

JAMA Oncol. 2025 Jan 2. doi: 10.1001/jamaoncol.2024.5648. Online ahead of print.
No abstract available

Plain language summary

This nonrandomized clinical trial reports outcomes for children with low-risk relapsed Hodgkin lymphoma treated with second-line chemotherapy and involved-field radiotherapy without autologous stem cell transplant.